Human mesenchymal stem cells (MSCs), also known as mesenchymal stromal cells or
medicinal signaling cells, are important adult stem cells for regenerative medicine, largely …

Osteoarthritis (OA) is a widespread clinical disease characterized by cartilage degeneration
in middle-aged and elderly people. Currently, there is no effective treatment for OA apart …

MSCs products as well as their derived extracellular vesicles, are currently being explored
as advanced biologics in cell-based therapies with high expectations for their clinical use in …

Regenerative medicine is a rapidly advancing field that aims to restore, replace, or
regenerate damaged tissues and organs using advanced biomedical techniques. Its …

Osteoarthritis (OA) is a degenerative multifactorial disease with concomitant structural,
inflammatory, and metabolic changes that fluctuate in a temporal and patient-specific …

The evolution of tissue engineering and 3D bioprinting has allowed for increased
opportunities to generate musculoskeletal tissue grafts that can enhance functional and …

Slaughterhouses produce large quantities of biological waste, and most of these materials
are underutilized. In many published reports, the possibility of repurposing this form of waste …

The use of mesenchymal stem cells (MSCs) for clinical purposes has skyrocketed in the past
decade. Their multilineage differentiation potentials and immunomodulatory properties have …

Aim Bone marrow-derived mesenchymal stem cells (BM-MSCs) are the most well-studied
and characterised stem cell types. This review was undertaken of the current available …

Mesenchymal stem/stromal cells (MSCs) have been evaluated in> 1500 clinical trials, but
outcomes remain suboptimal because of knowledge gaps in quality attributes that confer …